Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00753493 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00753493 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 20 participants.
The verdict
NCT00753493, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The aims of this study are to determine, in adult patients on maintenance topiramate therapy, the steady-state pharmacokinetics and safety of orally and intravenously administered topiramate.
Interventions
- DRUG intravenous topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-08 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00753493
The ClinicalTrials.gov registry entry for NCT00753493 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which intravenous topiramate is the first listed.
NCT00753493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00753493 about?
NCT00753493 is a clinical study titled "Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients". The aims of this study are to determine, in adult patients on maintenance topiramate therapy, the steady-state pharmacokinetics and safety of orally and intravenously administered topiramate.
What is the current status of trial NCT00753493?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2008-08. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00753493?
The interventions under investigation include: intravenous topiramate (DRUG).
Who is sponsoring clinical trial NCT00753493?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.